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Human Microbiome plays a key role in maintaining a healthy state by imparting normal metabolism and immunity to the host. In fact maintenance of good health has been contributed to the presence of healthy microbiome in human beings [1] . Any imbalance can lead to many diseases and make humans susceptible to attack by a variety of pathogens. While smooth functioning of the metabolic pathways ensures fitness and a state of well-being [2] , a strong correlation has been established between human health and microbial diversity, which harbors on and within the body [3, 4] . Recent estimates have revealed that our body is inhabited by as many bacteria as our body cells [5] . Skin harbours a wide range of microbes, the dominant ones being those belonging to Bacteroidetes, Corynebacteria, Propionibacteria, Proteobacteria, and Staphylococcus [6] . These microbes help in protecting skin from getting infected by pathogens. Within the human gut, bacteria belonging to around 160 species have been identified [7] and 44-48% of the total population is represented by Firmicutes and Bacteroidetes [8, 9] . There are various factors, which modulate the human gut flora including diet [10] , diseases like rheumatoid arthritis [11] , type I diabetes [12] , obesity [13] and inflammation of gut due to IBD and Crohn disease [14] . These studies have shown a significant shift in the community of gut microbes between healthy and diseased individuals mainly in lifestyle diseases [15] . But the role of gut microflora in infectious diseases like tuberculosis (TB) and the impact of antibiotic treatment has not been studied to great extent worldwide with only a few reports [16, 17] concerning the dysbiosis in the diversity of gut microflora during TB infection. Additionally, there is no study from the Indian subcontinent that took into account the shift in the bacterial community of gut and the functional implications of microbes on the gut-lung axis, especially during tuberculosis.
Tuberculosis (TB) has high burden both socially and economically in a developing country like India. The patients are prescribed with directly observed treatment, short course (DOTS) regimen and the treatment can extend up to 6-9 months. The treatment using the DOTS regimen has led to instances of Multi-Drug Resistant (MDR) in strains of Mycobacterium tuberculosis. MDR strains are very difficult to treat as M. tuberculosis has evolved in a way that it can develop resistance by way of developing mutation against multiple antibiotics if exposed for prolong duration below minimum inhibitory concentration (MIC) [18] . Therefore, studying the modulation of gut microbiome can provide insights into the pathophysiology of the infectious disease and thus can open new avenues for the research and development of new drugs and therapies for curing the disease. Restoration of gut microbiota has been shown as an effective treatment for patients suffering from Clostridium difficile infection (CDI) [19] and this can act as a primer for initiating therapies based on probiotics and faecal microbiome transplant.
A few attempts have been made to catalog the diversity of gut microbes in Indian ethnic cohort. But the majority of these studies reported only the taxonomic diversity of normal individuals like children [20] , tribal people [21] , or individuals suffering from type-I diabetes [22] , IBD and colon cancer [23] . The major lacunae of these study were the absence of any functional characterization of the modified gut microflora and absenteeism of information about their role in maintaining a normal state and diseased conditions among the Indian cohort. To bridge this gap in knowledge, Indian researchers from the Department of Zoology, University of Delhi, Department of Plant Molecular Biology, University of Delhi and CSIR-Institute of Genomics and Integrative Biology, Delhi by a team led by Prof. Yogendra Singh and Prof. Rup Lal have planned and executed a study for deciphering dysbiosis in gut microflora of individuals suffering from tuberculosis in an Indian ethnic cohort [24] . The study recently published in Environmental Microbiology [24] has reported for the first time an in-depth functional characterization of gut microflora in Indian subjects. The investigators compared the taxonomic and functional diversity of gut microbiome from fecal samples of six treatment-naïve TB patients and follow up the same patients, receiving directly observed treatment, short course (DOTS) regimen, 1 week and 1 month after the beginning of treatment. Six healthy household contacts (HCs) were chosen as the controls to rule out biases of genetic background and influence of the environmental conditions.
They complimented the results from 16S amplicon sequencing with functional disparities obtained from shotgun sequencing [24] . Results revealed the abundance of Prevotella and Bifidobacterium in healthy household contacts (Control samples) whereas bacteria from different genera like Faecalibacterium, Roseburia, Eubacterium, and Phascolarctobacterium were plentiful in the patients that have not received any medication. These genera represent small chain fatty acid (SCFA) producers and had pathways for butyrate and propionate production. Enriched metabolism of butyrate and propionate led to reduced biosynthesis of vitamins and amino acids leading to hypercholesterolemia and impairment of immune system. The diseased individuals also had an abundance of M. tuberculosis which might have invaded the respiratory system. The decline in Prevotella abundance has been postulated to allow the increase in microbial diversity of these propionate and butyrate producers. In brief, there were significant taxonomic and functional alterations in the gut microbiome of control and diseased samples. The authors also attempted to unravel the effect of antibiotics on gut microbiome of the diseased individual, they found a drastic reduction of M. tuberculosis population but no other major taxonomic recovery was observed till 1 month of DOTS treatment. Despite small cohort size, statistically significant differences in microbial composition were obtained between the groups. The results obtained from this pilot study provide insights into the role played by the GM in a pulmonary infectious disease. Nonetheless, this study was successful in paving new directions for planning future large-scale epidemiological studies for Indian populations focusing on microbiome analysis of the patients and deduces the holistic map to develop strategies in treating infectious disease using pro-biotics and nutritional supplements rather than antibiotics and formulate preventive strategies through dietary changes. To study the role of antibiotics, the timeline of sampling must have been more, but still, this study can act as a pilot for an in-depth analysis that can be done in the future increasing our understanding on the impact of antibiotics and restoration of gut microbiome at the end of the treatment (Fig. 1) . Fig. 1 Microbial dysbiosis along a gut-lung axis in TB infected Indian population. Prevotella is abundant genera in gut microflora of healthy Indian individuals. Infection by M. tuberculosis causes a dysbiosis with increase abundance of small chain fatty acid (SCFA) producers like Faecalibacterium, Roseburia, Eubacterium, and Phascolarctobacterium that had pathways for butyrate and propionate production
